HER2/Neu Positive Active Not Recruiting Phase 1 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02152943Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsTreatment